(c) 2024 PillSync.com

atorvastatin calcium 40 mg

1 INDICATIONS AND USAGE Atorvastatin calcium tablets are indicated: To reduce the risk of: Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: Adults with primary hyperlipidemia. Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). As an adjunct to diet for the treatment of adults with: Primary dysbetalipoproteinemia Hypertriglyceridemia Atorvastatin calcium tablets are an HMG-CoA reductase inhibitor (statin) indicated ( 1 ): To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD. o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD. o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD. As an adjunct to diet to reduce low-density lipoprotein (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). As an adjunct to other LDL-C-lowering therapies to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia. As an adjunct to diet for the treatment of adults with: o Primary dysbetaliproteinemia. o Hypertriglyceridemia.

Biocon Pharma Inc.


4 weeks ago OVAL WHITE A4 atorvastatin calcium 40 mg

OVAL WHITE A4

4 weeks ago OVAL WHITE A4 atorvastatin calcium 40 mg

A4 OVAL WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING

ATORVASTATIN CALCIUM tablets 10 mg debossed with “A6” on one side and plain on the other side. HDPE Bottle 90's count with child resistant closure NDC 70377-077-11 HDPE Bottle 500's count NDC 70377-077-12 HDPE Bottle 1000's count NDC 70377-077-13

ATORVASTATIN CALCIUM tablets 20 mg debossed with “A5” on one side and plain on the other side. HDPE Bottle 90's count with child resistant closure NDC 70377-078-11 HDPE Bottle 500's count NDC 70377-078-12 HDPE Bottle 1000's count NDC 70377-078-13

ATORVASTATIN CALCIUM tablets 40 mg debossed with “A4” on one side and plain on the other side. HDPE Bottle 90's count with child resistant closure NDC 70377-079-11 HDPE Bottle 500's count NDC 70377-079-12 HDPE Bottle 1000's count NDC 70377-079-13

ATORVASTATIN CALCIUM tablets 80 mg debossed with “A3” on one side and plain on the other side. HDPE Bottle 90's count with child resistant closure NDC 70377-080-11 HDPE Bottle 500's count NDC 70377-080-12 HDPE Bottle 1000's count NDC 70377-080-13 Storage Store at 20°C to 25°C (68°F to 77°F) [see USP Controlled Room Temperature].


More pills like OVAL A4












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site